🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Amicus Therapeutics, Inc.

FOLD Healthcare
$14.46 +$0.03 (0.21%)
Market Cap: $4.54 B
Gurus Holding
9
Popularity Rank
#682
% of Shares Held
3.38%
Net Activity (Q4 2025)
+$9.17 M

Guru Ownership Trend

Guru Analysis for Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics, Inc. (FOLD), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 9 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $153.58 M.

Top institutional holders include George Soros and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $9.17 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 432.6%. Conversely, Steven Cohen reduced exposure by 71.1%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q4 2025)

+$92.04 M
Total Buy Value
New Buys 3
Additions 3
-$82.87 M
Total Sell Value
Reductions 2
Sold Out 0

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
6

FAQs for Amicus Therapeutics, Inc. (FOLD)

Major holders include George Soros ($71.2 M), Steven Cohen ($29.45 M), Renaissance Technologies (RenTech) ($17.25 M). According to the latest reported data, 9 tracked investment managers collectively hold approximately 10.62 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $9.17 M, with 6 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited FOLD. The total reported sell value was $82.87 M.

Yes, 3 managers opened new positions in FOLD, and 3 increased their existing holdings. The total reported buy value was $92.04 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.82% New Buy 5,000,000 $71.2 M Q4 2025
0.03% Reduce -71.1% 2,068,454 $29.45 M Q4 2025
0.03% Reduce -37.6% 1,211,693 $17.25 M Q4 2025
0.01% Add 139.0% 966,795 $13.77 M Q4 2025
0.02% Add 432.6% 900,000 $12.82 M Q4 2025
0.01% 165,485 $2.36 M Q4 2025
0.01% Add 0.7% 139,551 $1.99 M Q4 2025
0.03% New Buy 137,000 $1.95 M Q4 2025
0.00% New Buy 32,274 $459,582 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form